Anzeige
Mehr »
Dienstag, 30.09.2025 - Börsentäglich über 12.000 News
Seltene Ausgangslage: Unbekannter Kupfer-Explorer mit spekulativem Potenzial
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A41H07 | ISIN: US8549362007 | Ticker-Symbol: W3T0
NASDAQ
29.09.25 | 21:59
3,100 US-Dollar
0,00 % 0,000
Branche
Elektrotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
STARDUST POWER INC Chart 1 Jahr
5-Tage-Chart
STARDUST POWER INC 5-Tage-Chart

Aktueller Chart STARDUST POWER Aktie

Chart vergleichen mit:

Firmenname, WKN, ISIN oder Aktien-Kürzel

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%
Chart-Typ:
Zeitraum:
 
STARDUST POWER INC-Investoren interessieren sich auch für diese Wertpapiere
Aktien Europa: Leichte Gewinne zum Wochenauftakt AMSTERDAM/LONDON/PARIS/ZÜRICH (dpa-AFX) - Europas wichtigste Aktienmärkte starten am Montag zunächst freundlich in die neue Woche. Allerdings blieb die Risikobereitschaft verhalten angesichts der bleiben...
► Artikel lesen
CAC 40 Up 0.6%; STMicroElectronics Rises SharplyBRUSSELS (dpa-AFX) - Despite data showing a contraction in France's private sector activity in the month of September, French stocks are up firmly in positive territory Tuesday afternoon with...
► Artikel lesen
STMicroelectronics N.V.: STARLight Project chosen as the European consortium to take the lead in next-generation Silicon Photonics on 300mm wafersSTARLight Project chosen as the European consortium to take the lead in next-generation Silicon Photonics on 300mm wafers 24 leading technology companies and universities from 11 EU countries are...
► Artikel lesen
VivoSim Labs, Inc.: VivoSim Labs Appoints Tony Lialin as Chief Commercial OfficerSAN DIEGO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the "Company" or "VivoSim Labs"), a pharmaceutical and biotechnology services company that is focused on providing testing...
► Artikel lesen
VivoSim Labs, Inc.: VivoSim Announces Emergence from Stealth Mode To Provide Technologies for FDA Turn Away from Animal Models, $10B+ MarketSAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the "Company") announced that it has emerged from stealth mode to dramatically impact drug discovery and development....
► Artikel lesen
Organovo, Inc.: Organovo Provides Update on Cash and Nasdaq Continued Listing RequirementsSAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) ("Organovo" or the "Company"), a clinical stage biotechnology company focused on developing novel treatment approaches...
► Artikel lesen
INOVIO Pharmaceuticals, Inc.: INOVIO Reports Second Quarter 2025 Financial Results and Recent Business HighlightsOn track to submit Biologics License Application (BLA) for INO-3107 in 2H25, with the goal of file acceptance by year end Completed design verification (DV) testing...
► Artikel lesen
INOVIO Pharma Announces Proposed Public OfferingWASHINGTON (dpa-AFX) - INOVIO Pharmaceuticals Inc. (INO) announced that it intends to offer and sell shares of its common stock (or pre-funded warrants to purchase its common stock in lieu thereof)...
► Artikel lesen
INOVIO Pharmaceuticals, Inc.: INOVIO Reports First Quarter 2025 Financial Results and Recent Business HighlightsOn track to begin rolling submission of Biologics License Application (BLA) for INO-3107 as a potential treatment for recurrent respiratory papillomatosis (RRP)...
► Artikel lesen